about
Cell(s) of Origin of Langerhans Cell HistiocytosisFunctional characterization of the human dendritic cell immunodeficiency associated with the IRF8(K108E) mutationExome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency.The fate and lifespan of human monocyte subsets in steady state and systemic inflammationHuman dermal CD14⁺ cells are a transient population of monocyte-derived macrophagesIRF8 mutations and human dendritic-cell immunodeficiency.Haematopoietic and immune defects associated with GATA2 mutation.Human tissues contain CD141hi cross-presenting dendritic cells with functional homology to mouse CD103+ nonlymphoid dendritic cellsA comparative study of reduced dose alemtuzumab in matched unrelated donor and related donor reduced intensity transplants.Single-gene association between GATA-2 and autoimmune hepatitis: A novel genetic insight highlighting immunologic pathways to disease.Targeted treatment of brainstem neurohistiocytosis guided by urinary cell-free DNA.Early Molecular Stratification of High-risk Primary Biliary Cholangitis.Biallelic mutations in IRF8 impair human NK cell maturation and functionThe evolution of cellular deficiency in GATA2 mutationBRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups.Human mononuclear phagocyte system reunited.Adaptive NK cells can persist in patients with GATA2 mutation depleted of stem and progenitor cellsDendritic cell analysis in primary immunodeficiencySensitizing primary acute lymphoblastic leukemia to natural killer cell recognition by induction of NKG2D ligands.Single amino acid charge switch defines clinically distinct proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1)-associated inflammatory diseases.Human fetal dendritic cells promote prenatal T-cell immune suppression through arginase-2.The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency.Langerin-expressing dendritic cells in human tissues are related to CD1c+ dendritic cells and distinct from Langerhans cells and CD141high XCR1+ dendritic cells.CD1c+ blood dendritic cells have Langerhans cell potential.Population of Monocyte-Derived Macrophages.Rapid detection of dendritic cell and monocyte disorders using CD4 as a lineage marker of the human peripheral blood antigen-presenting cell compartmentDendritic cell, monocyte, B and NK lymphoid deficiency defines the lost lineages of a new GATA-2 dependent myelodysplastic syndrome.BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups.Fusarium dimerum infection in a stem cell transplant recipient treated successfully with voriconazole.Monocyte, Macrophage, and Dendritic Cell Development: the Human Perspective.Biallelic interferon regulatory factor 8 mutation: A complex immunodeficiency syndrome with dendritic cell deficiency, monocytopenia, and immune dysregulation.A novel IKAROS haploinsufficiency kindred with unexpectedly late and variable B-cell maturation defects.In vivo T-depleted reduced intensity transplantation for GATA2-related immune dysfunction.Successful outcome following allogeneic hematopoietic stem cell transplantation in adults with primary immunodeficiency.Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults.Seminars in Cell and Developmental Biology Human Dendritic Cell Immunodeficiencies.Human dendritic cell subsets: an update.Impact of Alemtuzumab Scheduling on Graft-versus-Host Disease after Unrelated Donor Fludarabine and Melphalan Allografts.Timely follow-up of a GATA2 deficiency patient allows successful treatment.Ikaros family zinc finger 1 regulates dendritic cell development and function in humans.
P50
Q28087231-3F0D2299-6611-4C77-9AE1-2EDA56774B37Q28119180-2F96E776-CEDD-4367-B012-50894AE1E3ECQ30368393-50CB6A23-36B2-4467-A0E5-D0E8CCB0A977Q33886544-D78DD911-66D6-41F3-9454-9DAC687A8843Q34244161-B86A290B-7272-463D-93C1-611715CBA8E6Q35106002-6A6CE0A4-7D61-484E-A9A5-E9634D18035AQ35535835-93602B98-E157-4F02-8459-EBE9D248336CQ36333494-54E8729D-3E77-4977-A380-B7AE15297593Q36532550-85085D56-562A-4794-8EAE-35D21EA73882Q36777826-223C3B7E-822C-4349-AFEA-CD26E0F8A191Q37394955-8DAFE048-3862-4E30-A115-9C87C05264EDQ37510232-99984984-D748-4CCC-AC0C-B5B3C89334CDQ37545040-EA48F185-1A72-464D-9C8E-2E680A6CFD4BQ37564769-B3CB4100-ACA2-4207-ADE6-3B47279EE181Q37689383-28681B2B-94FB-472D-ADA8-ECF8B0CB6846Q38488997-39EE9CCE-1869-46DA-B11A-80F2EC9B8045Q38956465-5875B85D-65E8-4C8B-A5BC-35E115B49A77Q38984250-F47B9377-F1CC-49CB-AF04-B7B070118C0DQ39323511-EBCA39BA-15FA-4329-82E0-8743F028FD03Q41195612-6F5183EE-147A-43B8-9B23-7ACE1E3E8F38Q41412741-2C60CEAA-47A2-438F-B6D3-3B95C4C0C0C0Q41821656-576F4CA8-6CE2-4DD8-8371-7986297E8E83Q42108118-BB8194E2-A1BD-4070-BC87-0A9D56AAEE55Q42171834-D6A61B48-7471-434F-9A5F-E49A329504D6Q42370367-643E7872-0AC7-4CD1-AE8F-564B83DA23CBQ42774394-9990FF93-C874-4503-BACB-CB9E9D3EEF76Q42852347-0FE69314-F2AA-41F4-B2E9-45A446A3F06AQ43139632-F3D0750D-4C90-4313-B535-36277B5224FEQ45054608-5723BA0C-5134-4516-AA64-A4052CF6B130Q46471501-F402F0CD-7A8E-4FC6-955D-947FCF5E6A9BQ47412930-185856A2-D1D6-402B-A9CA-958FEA901803Q49061429-34C2ED5B-27FD-4E85-96F6-6DC76D57BFAFQ49359673-3D4975F9-B7C5-4D86-B658-4E212741E8FCQ49568332-50573828-3665-48B2-90E5-1025E31CB78BQ49568680-2D1AA205-CE93-453D-A6F7-30050F432E43Q49923104-62129280-D2BA-4DE7-A0E0-8F42DBCC19EBQ50125373-EC2C55B1-0DC1-454D-8102-C2F3820F6D88Q50207614-528931BF-7D59-402B-ABDF-B612486BAAECQ50859392-E4599847-342E-4EB4-8240-CC66D5A476E9Q52723704-998686E1-0D85-4228-BE1A-DB86772C21AB
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Venetia Bigley
@ast
Venetia Bigley
@en
Venetia Bigley
@es
Venetia Bigley
@nl
Venetia Bigley
@sl
type
label
Venetia Bigley
@ast
Venetia Bigley
@en
Venetia Bigley
@es
Venetia Bigley
@nl
Venetia Bigley
@sl
prefLabel
Venetia Bigley
@ast
Venetia Bigley
@en
Venetia Bigley
@es
Venetia Bigley
@nl
Venetia Bigley
@sl
P106
P31
P496
0000-0002-3017-2474